Document is current
Any future updates will be listed below
-
Authors
Tharao, Wangari
Nyoni, Thabani https://orcid.org/0000-0002-0100-6258
Daftary, Amrita
Bullock, Sandra
Blot, Soraya
Pierre-Pierre, Valerie
Loutfy, Mona
Kaul, Rupert
Tan, Darrell
Rachlis, Anita
Cooper, Curtis
Salit, Irving
Luyombya, Henry
Ryan, Shannon Thomas
Calzavara, Liviana
,
-
Funding
Funding for this research was provided by:
Ontario HIV Treatment Network (ROG G870)
- License Information
-
More Information
Article History
Received: 14 May 2024
Accepted: 18 December 2024
First Online: 24 February 2025
Declarations
:
: The MSAFIRI Study was approved by the following: Hospital Research Ethics Board (REB# 14–138); Sunnybrook et al. (REB# 196–2014); Toronto General Hospital’s Research Ethics Board (REB# 14–7686-BE / University Health Network UHN CAPCR ID 14–7686); Ottawa Hospital Research Institute’s affiliated institutional Research Ethics Boards (REBs): University of Toronto Umbrella Ethics Board (Protocol Reference# 29586); the Maple Leaf Medical Clinic, which is covered under the University of Toronto’s ethics approval (Protocol Reference# 29586); St. Michael’s Research Ethics Board (OHSN-REB #20150802-01H). The MSAFIRI Study was conducted between January 2015 and March 2017 in Ontario, targeting men and women who identify as African, Caribbean, and Black (ACB) and who were infected with HIV post-immigration in Ontario, Canada.
: Informed consent was obtained from all subjects.
: Not applicable.
: The authors declare no competing interests.
